True Wealth Design LLC Takes $31,000 Position in Omega Healthcare Investors, Inc. (NYSE:OHI)

True Wealth Design LLC purchased a new position in shares of Omega Healthcare Investors, Inc. (NYSE:OHIFree Report) in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 771 shares of the real estate investment trust’s stock, valued at approximately $31,000.

Other large investors have also modified their holdings of the company. Versant Capital Management Inc bought a new position in Omega Healthcare Investors in the 2nd quarter worth about $26,000. UMB Bank n.a. boosted its position in shares of Omega Healthcare Investors by 353.4% during the third quarter. UMB Bank n.a. now owns 662 shares of the real estate investment trust’s stock worth $27,000 after buying an additional 516 shares during the period. DiNuzzo Private Wealth Inc. acquired a new position in shares of Omega Healthcare Investors during the third quarter worth approximately $33,000. V Square Quantitative Management LLC grew its holdings in Omega Healthcare Investors by 49.5% in the 3rd quarter. V Square Quantitative Management LLC now owns 976 shares of the real estate investment trust’s stock worth $40,000 after buying an additional 323 shares in the last quarter. Finally, Truvestments Capital LLC acquired a new stake in Omega Healthcare Investors in the 3rd quarter valued at approximately $43,000. Institutional investors and hedge funds own 65.25% of the company’s stock.

Insider Activity

In other Omega Healthcare Investors news, COO Daniel J. Booth sold 56,725 shares of the business’s stock in a transaction dated Friday, September 27th. The stock was sold at an average price of $40.25, for a total transaction of $2,283,181.25. Following the sale, the chief operating officer now owns 100,000 shares in the company, valued at approximately $4,025,000. The trade was a 36.19 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Robert O. Stephenson sold 22,542 shares of the company’s stock in a transaction dated Friday, September 27th. The shares were sold at an average price of $40.19, for a total transaction of $905,962.98. Following the sale, the chief financial officer now directly owns 183,076 shares of the company’s stock, valued at $7,357,824.44. This represents a 10.96 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.37% of the stock is currently owned by company insiders.

Omega Healthcare Investors Trading Down 0.1 %

Omega Healthcare Investors stock opened at $40.61 on Monday. Omega Healthcare Investors, Inc. has a 1 year low of $27.53 and a 1 year high of $44.42. The firm’s 50 day moving average price is $40.61 and its two-hundred day moving average price is $37.40. The firm has a market cap of $10.96 billion, a price-to-earnings ratio of 29.86, a price-to-earnings-growth ratio of 1.26 and a beta of 0.99. The company has a debt-to-equity ratio of 1.10, a quick ratio of 6.48 and a current ratio of 6.48.

Omega Healthcare Investors Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Monday, November 4th were given a dividend of $0.67 per share. This represents a $2.68 dividend on an annualized basis and a dividend yield of 6.60%. The ex-dividend date of this dividend was Monday, November 4th. Omega Healthcare Investors’s dividend payout ratio (DPR) is presently 197.06%.

Wall Street Analyst Weigh In

OHI has been the subject of several recent analyst reports. BNP Paribas raised Omega Healthcare Investors from a “neutral” rating to an “outperform” rating and set a $49.00 price target for the company in a research note on Thursday, October 31st. Royal Bank of Canada increased their target price on shares of Omega Healthcare Investors from $39.00 to $43.00 and gave the company a “sector perform” rating in a research report on Monday, November 11th. Wells Fargo & Company restated an “overweight” rating and set a $43.00 price target (up from $40.00) on shares of Omega Healthcare Investors in a research report on Tuesday, October 1st. BMO Capital Markets increased their price objective on shares of Omega Healthcare Investors from $44.00 to $45.00 and gave the company a “market perform” rating in a report on Monday, October 7th. Finally, Berenberg Bank initiated coverage on shares of Omega Healthcare Investors in a research note on Friday, October 18th. They set a “buy” rating and a $45.00 price objective on the stock. Seven equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $40.00.

Get Our Latest Stock Analysis on Omega Healthcare Investors

About Omega Healthcare Investors

(Free Report)

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.

Further Reading

Want to see what other hedge funds are holding OHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Omega Healthcare Investors, Inc. (NYSE:OHIFree Report).

Institutional Ownership by Quarter for Omega Healthcare Investors (NYSE:OHI)

Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.